Showing results (201-210 of 633) with videos related to
Sort By:
Pageof 64
Trends in Neurosciences|February 13, 2001
Atypical neural messengersD E Barañano, C D Ferris, S H SnyderScience (New York, N.Y.)|May 6, 1983
Recognition sites for norepinephrine uptake: regulation by neurotransmitterC M Lee, J A Javitch, S H SnyderMolecular Pharmacology|July 1, 1984
[3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sitesJ A Javitch, R O Blaustein, S H SnyderBiochemical and Biophysical Research Communications|May 16, 1983
[3H]Captopril binding to membrane associated angiotensin converting enzymeS M Strittmatter, M S Kapiloff, S H SnyderBiochemical and Biophysical Research Communications|March 29, 1983
Enkephalin convertase: potent, selective, and irreversible inhibitorsL D Fricker, T H Plummer, S H SnyderMolecular Pharmacology|March 1, 1984
Tissue heterogeneity of calcium channel antagonist binding sites labeled by [3H]nitrendipineR J Gould, K M Murphy, S H SnyderLife Sciences|November 5, 1984
125I-Spiperone: a novel ligand for D2 dopamine receptorsA L Gundlach, B L Largent, S H SnyderThe Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 1, 1985
Differential visualization of dopamine and norepinephrine uptake sites in rat brain using [3H]mazindol autoradiographyJ A Javitch, S M Strittmatter, S H SnyderProceedings of the National Academy of Sciences of the United States of America|April 1, 1985
Protein kinase C regulates ionic conductance in hippocampal pyramidal neurons: electrophysiological effects of phorbol estersJ M Baraban, S H Snyder, B E AlgerJournal of Cardiovascular Pharmacology|January 1, 1987
Physiological and pharmacological correlates of calcium antagonist receptorsJ A Wagner, I J Reynolds, S H SnyderPageof 64